← Leaderboards
Daniel J McBride
Johns Hopkins University
$591,793
Attributed
$591,793
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$591,793 · 3
By mechanism
R03$297,000 · 1
R29$229,624 · 1
M01$65,169 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Seema Khurana$9,386,019
- Frederick L Brancati$22,508,444
- William W Eaton$22,660,492
- David Sidransky$59,922,938
- Joseph B. Margolick$86,818,342
Others in their field
Top investigators on “Polymerase Chain Reaction”
- Richard A Gibbs · Baylor College Of Medicine$161,803,490
- Norman Wolmark · Nsabp Foundation, Inc.$79,506,229
- David Heimbrook · Leidos Biomedical Research, Inc.$70,580,438
- Constance Ann Benson · University Of California, San Diego$66,635,731
- Eric S Lander · Whitehead Institute For Biomedical Res$52,964,838
- Thomas William Geisbert · Boston University Medical Campus$36,787,680
Research focus
Polymerase Chain ReactionHuman SubjectClinical ResearchGenetic SusceptibilityBlood ChemistryDna PrimersMaleOsteoporosisBone DensityGenetic MappingTissue /Cell CultureBone Marrow TransplantationCell ProliferationCollagenGene ExpressionGene TherapyGenetically Modified AnimalsGenetic TranscriptionMedical Outreach /Case FindingMessenger RnaNucleic Acid HybridizationNucleic Acid SequenceOsteoblastsOsteogenesis Imperfecta
Grant awards (7)
Gluten Sensitivity in the Old Order Amish$148,500
R03 · FY2005 · DK
Gluten Sensitivity in the Old Order Amish$148,500
R03 · FY2004 · DK
GENETICS OF OSTEOPOROSIS IN MEN$0
M01 · FY2002 · RR
BONE MARROW TRANSPLANTATION IN OIM--A GENE THERAPY MODEL$117,063
R29 · FY2001 · AR
GENETICS OF OSTEOPOROSIS IN MEN$0
M01 · FY2001 · RR
BONE MARROW TRANSPLANTATION IN OIM--A GENE THERAPY MODEL$112,561
R29 · FY2000 · AR
GENETICS OF OSTEOPOROSIS IN MEN$65,169
M01 · FY2000 · RR